Home Search Search All Website Search for website content Search Popular search terms: Biotech Cell and Gene Therapies Consulting Early Clinical Medical Device Oncology Rare & Orphan Diseases Real World Evidence Site & Patient Recruitment Strategic Solutions Regulatory Intelligence Categories Social media ICON Plc Customer advocacy is not a trend, it’s a transformation. It represents a shift from service to stewardship and from expertise to empathy. It’s about recognising that behind every clinical milestone, every regulatory subm... 14h 1 View post View webpage ICON Plc In the dynamic world of life sciences, the consultancy sector is undergoing a transformation as cost pressures increase, speed to market needs accelerate and technology permeates every aspect. Against this backdrop, cl... 14h View post View webpage ICON Plc Attending AASLD 2025? Speak with our experts at booth #1041 to learn about our experience-driven country feasibility and site selection, hepatology-specific strategies for recruitment and retention, and advanced imaging ... 16h 1 View post View webpage ICON Plc PubsHub Journals & Congresses scans for predatory practices, and suspicious journals and congresses. Trust it to protect your research work and help you make better informed publishing decisions. Get more info and a demo... 21h 1 View post View webpage ICON Plc Attending #ObesityWeek on Nov 4–7? Meet us as booth \#520 to learn how our comprehensive lab and imaging capabilities support high-quality, large-scale obesity studies. From AI-driven imaging biomarkers to expert guidanc... 23h View post View webpage ICON Plc We’re heading to #ISPOREurope in Glasgow (Nov 9–12)! Visit ICON at Booth 824 to explore how we advance HEOR, RWE, and market access strategies for better patient outcomes. https://ow.ly/eumN50XfmbW #ISPOREurope #HEOR #... 23 Oct View post View webpage ICON Plc ICON reports third quarter 2025 results. Quarter three revenue was $2,042.8 million representing an increase of 1.3% on quarter two 2025. Net business wins in the quarter of $2,086 million, representing an increase of 1.... 22 Oct View post View webpage ICON Plc USP compounding may be fast — but is it costing you quality, compliance, and insight? Join our webinar to learn why GMP is the smarter choice for early phase trials. During this session we will discuss: • The differences... 22 Oct 1 View post View webpage ICON Plc Join ICON at #CPHIFrankfurt, taking place from 28 to 30 October at Messe Frankfurt to discover how our Accelerated Pharmaceutical Solutions are built to meet the demands of a fast-moving industry—combining global reach, ... 22 Oct 2 View post View webpage ICON Plc ICON is proud to sponsor the World Drug Safety Congress, 4–6 November in Boston, MA. As a global leader in pharmacovigilance, ICON partners with biopharma and medical device companies of all sizes to strengthen patient ... 22 Oct 1 View post View webpage ICON Plc Are you going to CPHI? If so come along to our VIP in-person event on Tuesday 28th October where our panel of industry experts will discuss the challenges around accelerating timelines and reducing costs in early clinica... 22 Oct 3 View post View webpage ICON Plc By integrating drug substance, formulation development, real-time manufacturing, and clinical testing, we streamline the entire process—cutting up to 12+ months in development time and significantly reducing costs. Del... 22 Oct View post View webpage
